Sramana Mitra: I’m going to switch gear again to the open problems. What is your analysis of the whole gene editing and the CRISPR world? What is possible? What problems can be solved in the short, medium, and long term? Aneesh Chopra: This is an area that will go in three directions. We’re still in
Sramana Mitra: In this use case that you mentioned, what are they doing with that information? Aneesh Chopra: Establishing contracts. Physicians negotiate contracts with insurance companies on a fee-for-service basis. If I see a patient, will you pay me $100? In parallel, there is a related network function to say, “I’m not as interested in
Sramana Mitra: I want to close this segment of our discussion with a question. What, in your mind, are some of the open problems that you would like startups to go solve? Aneesh Chopra: Let’s go through the healthcare discussion we’ve had and identify a few examples along the way. In my dream world, there
Sramana Mitra: What is your analysis of their potential to weave them into society? Aneesh Chopra: We are going to continue down the curve on the cost side. Early in the Obama administration, it cost roughly $2,000 to sequence a genome. We set a goal to get that profitably delivered for under $100 and we’re
Sramana Mitra: The innovation engine of the country also applies to the middle layer, right? Aneesh Chopra: Now it will be. Earlier in the Obama administration, we launched an initiative called Startup America. You could imagine that you’re building Startup Global is to drive more entrepreneurs into the economy. As we know, startups have been
Aneesh offers a thoughtful and comprehensive analysis and vision of the innovation and entrepreneurship opportunities throughout the healthcare system. Fascinating conversation. Sramana Mitra: Let’s do a little intro and get some background. I know you have a very colorful background.